1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Zaiwen Fan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC EGFR-TK Inhibitor - Advanced Cancer, Lung Cancer, Nonsmall Cell | Phase 3 | Unknown | Zaiwen Fan | 80 | 2017-02-01 | 2017-01-04 |
Carcinoma, Non-Small-Cell Lung (1)
Endostatins (1)